Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Veelken

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Pflugers Archiv : European Journal of Physiology|September 12, 2020
Central processing of afferent renal pathways-significance and implicationsKristina Rodionova, Roland Veelken
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2002
Serotonin 5-HT(3) receptors on mechanosensitive neurons with cardiac afferentsPeter Linz, Roland Veelken
Journal of Hypertension|March 23, 2002
Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolvesRoland Veelken, Roland E Schmieder
Journal of the American Society of Nephrology : JASN|February 11, 2005
Type 2 diabetic nephropathy: never too early to treat?Karl F Hilgers, Roland Veelken
Nature Reviews. Nephrology|April 16, 2014
Renal denervation--implications for chronic kidney diseaseRoland Veelken, Roland E Schmieder
Journal of the American Society of Nephrology : JASN|October 2, 2021
Renal Nerve Ablation in Nephritis and BeyondKristina Rodionova, Tilmann Ditting, Roland Veelken
Journal of Molecular Medicine (Berlin, Germany)|July 15, 2009
Autonomous innervation in renal inflammatory disease-innocent bystander or active modulator?Tilmann Ditting, Gisa Tiegs, Roland Veelken
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 16, 2013
Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first resultsRoland Veelken, Johannes F E Mann
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Transient receptor potential vanilloid type 1 receptors in hypertensive renal damage: a promising therapeutic target?Tilmann Ditting, Roland Veelken, Karl F Hilgers
Deutsches Arzteblatt International|May 22, 2012
An experimental procedure paid for by the general publicJohannes Mann, Karl Hilgers, Roland Veelken, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Pflugers Archiv : European Journal of Physiology|September 12, 2020
Central processing of afferent renal pathways-significance and implicationsKristina Rodionova, Roland Veelken
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2002
Serotonin 5-HT(3) receptors on mechanosensitive neurons with cardiac afferentsPeter Linz, Roland Veelken
Journal of Hypertension|March 23, 2002
Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolvesRoland Veelken, Roland E Schmieder
Journal of the American Society of Nephrology : JASN|February 11, 2005
Type 2 diabetic nephropathy: never too early to treat?Karl F Hilgers, Roland Veelken
Nature Reviews. Nephrology|April 16, 2014
Renal denervation--implications for chronic kidney diseaseRoland Veelken, Roland E Schmieder
Journal of the American Society of Nephrology : JASN|October 2, 2021
Renal Nerve Ablation in Nephritis and BeyondKristina Rodionova, Tilmann Ditting, Roland Veelken
Journal of Molecular Medicine (Berlin, Germany)|July 15, 2009
Autonomous innervation in renal inflammatory disease-innocent bystander or active modulator?Tilmann Ditting, Gisa Tiegs, Roland Veelken
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 16, 2013
Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first resultsRoland Veelken, Johannes F E Mann
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Transient receptor potential vanilloid type 1 receptors in hypertensive renal damage: a promising therapeutic target?Tilmann Ditting, Roland Veelken, Karl F Hilgers
Deutsches Arzteblatt International|May 22, 2012
An experimental procedure paid for by the general publicJohannes Mann, Karl Hilgers, Roland Veelken, et al.
Pageof 8